Can These Medications Cause Bradycardia?
Yes, all three medications can cause bradycardia, though through different mechanisms and with varying likelihood: Cardura (doxazosin) has documented bradycardia as a postmarketing adverse effect, amlodipine can cause bradycardia particularly in overdose or acute intoxication (and rarely at therapeutic doses in elderly patients), while Flexeril (cyclobenzaprine) is not associated with bradycardia based on available evidence.
Cardura (Doxazosin)
Doxazosin is documented to cause bradycardia and cardiac arrhythmias in postmarketing surveillance data. 1
- The FDA label specifically lists bradycardia and cardiac arrhythmias under postmarketing adverse events for doxazosin 1
- Research demonstrates that doxazosin at 10 μM can prolong PR interval and induce arrhythmias, including complete inhibition of sinus rhythm in experimental models 2
- A withdrawal study in normotensive subjects showed that discontinuation of doxazosin resulted in bradycardia without hypotension, with decreased pulse rate on both day 2 and day 7 after withdrawal 3
Clinical Mechanism
- Doxazosin inhibits multiple cardiac ion channels including I(Na), I(Ca,L), I(to), and Iss, which can affect cardiac automatism and conduction 2
- The bradycardia appears related to effects on the AV nodal tissue through heterogeneous calcium channel blockade 2
Amlodipine
Amlodipine typically does not cause bradycardia at therapeutic doses, but can cause significant bradyarrhythmias in acute intoxication or overdose situations. 4, 5
At Therapeutic Doses
- The FDA label states that chronic oral administration of amlodipine "did not lead to clinically significant changes in heart rate" in normotensive patients with angina 4
- Amlodipine "does not change sinoatrial nodal function or atrioventricular conduction in intact animals or man" at therapeutic doses 4
- When combined with beta-blockers, no adverse effects on electrocardiographic parameters were observed in clinical studies 4
In Acute Intoxication
- Severe amlodipine intoxication can cause important bradyarrhythmias including low atrial rhythm, prolonged PR interval, atrioventricular block, and bundle branch blocks 5
- During acute intoxication, dihydropyridines like amlodipine lose their selective vascular action and can depress cardiac automatism and conduction 5
- A case report documented BRASH syndrome (Bradycardia, Renal failure, AV nodal blockade, Shock, Hyperkalemia) associated with amlodipine in an 89-year-old patient 6
Important Caveat
- While reflex tachycardia is the expected response to amlodipine's vasodilatory effects, elderly patients or those with renal impairment may paradoxically develop bradycardia 6, 7
- Drug interactions with SSRIs (fluoxetine, sertraline, paroxetine) can intensify amlodipine's side effects 8
Flexeril (Cyclobenzaprine)
There is no evidence in the provided literature that cyclobenzaprine causes bradycardia. Cyclobenzaprine is a muscle relaxant structurally related to tricyclic antidepressants, but bradycardia is not a recognized adverse effect of this medication based on the available evidence.
Clinical Recommendations
Monitoring Priorities
- For patients on doxazosin: Monitor heart rate regularly, particularly in elderly patients or those with baseline conduction abnormalities 1, 2
- For patients on amlodipine: Bradycardia risk is minimal at therapeutic doses, but monitor closely in elderly patients, those with renal impairment, or if overdose is suspected 4, 5, 6
- Be aware that combination therapy with beta-blockers and sodium channel blockers dramatically increases bradycardia risk, even months after medication initiation 9
High-Risk Scenarios
- Elderly patients (age >70) are at increased risk for medication-induced bradycardia 6, 9
- Patients with renal impairment may develop synergistic bradycardia with amlodipine through BRASH syndrome 6
- Concomitant use of CYP3A4 inhibitors with either amlodipine or doxazosin can increase drug levels and adverse effects 4, 1